ESR1 and breast carcinoma: However, RNF8 appears to have the opposite effect in tumor progression according to recent studies, because it promoted breast cancer proliferation and metastasis by affecting the Wnt/β-catenin pathway and activating the activity of transcription factors such as Twist and ERα 23-25.